Follow The Filings

FNRN

Earnings company data as of 10:00 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by FNRN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All FNRN insider trades
  • $101K bought by 3 insiders
  • $561K sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Richard M Martinez Director
    Sale
    $35K 2,000 shares at $17.51 2.7% of stake
    Traded Aug 13 Filed Aug 14
  2. Jean-Luc Servat Director
    Buy
    $17K 1,000 shares at $17.29 +22% to stake
    Traded Aug 12 Filed Aug 12
  3. Mark C Schulze Director
    Sale
    $109K 6,368 shares at $17.12 0.9% of stake
    Traded Aug 10–11 Filed Aug 12
  4. Mark C Schulze Director
    Sale
    $7,244 400 shares at $18.11 0.1% of stake
    Traded Aug 6 Filed Aug 11
  5. Jean-Luc Servat Director
    Buy
    $18K 1,000 shares at $18.22 +28% to stake
    Traded Aug 5–6 Filed Aug 7
  6. Mark C Schulze Director
    Sale
    $59K 3,232 shares at $18.40 0.4% of stake
    Traded Aug 4–5 Filed Aug 6
  7. Jeremiah Zachary Smith CEO
    Sale
    $120K 6,783 shares at $17.69 4.2% of stake
    Traded May 15 Filed May 18
  8. Mark C Schulze Director
    Sale
    $36K 2,000 shares at $17.79 0.3% of stake
    Traded May 12 Filed May 14
  9. Mark C Schulze Director
    Sale
    $53K 3,000 shares at $17.78 0.4% of stake
    Traded May 8 Filed May 11
  10. Kevin Spink CFO
    Sale
    $141K 8,271 shares at $17.04 15% of stake
    Traded May 4 Filed May 6
  11. Barbara A Hayes Director
    Buy
    $2,514 171 shares at $14.70 +1.4% to stake
    Traded Feb 18 Filed Feb 19
  12. Jean-Luc Servat Director
    Buy
    $21K 1,463 shares at $14.58 +73% to stake
    Traded Feb 18–19 Filed Feb 19
  13. Jean-Luc Servat Director
    Buy
    $29K 2,000 shares at $14.49 New stake
    Traded Feb 11–12 Filed Feb 12
  14. Richard Bedoya Director
    Buy
    $13K 893 shares at $14.49 +44% to stake
    Traded Feb 11 Filed Feb 12

Also filed in the last 12 months, not counted as buying or selling: 5 stock grants, 3 gifts, 2 share withholdings for taxes, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q FORM 10-Q
8-K 2.02,7.01,9.01
SCHEDULE 13G —
8-K 5.07
10-Q FORM 10-Q
8-K 2.02,7.01,9.01
8-K 8.01,9.01
DEF 14A FORM DEF 14A
8-K 7.01,8.01,9.01
8-K 8.01,9.01
10-K FORM 10-K
SCHEDULE 13G/A —
8-K 2.02,7.01,8.01,9.01
8-K 5.03,9.01
8-K 5.02,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.